BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26004343)

  • 21. von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids.
    Lieubeau-Teillet B; Rak J; Jothy S; Iliopoulos O; Kaelin W; Kerbel RS
    Cancer Res; 1998 Nov; 58(21):4957-62. PubMed ID: 9810005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model.
    Weber KL; Pathak S; Multani AS; Price JE
    J Urol; 2002 Aug; 168(2):774-9. PubMed ID: 12131367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoclast-mediated osteolysis in bone metastasis from renal cell carcinoma.
    Aoki J; Yamamoto I; Hino M; Shigeno C; Kitamura N; Sone T; Shiomi K; Konishi J
    Cancer; 1988 Jul; 62(1):98-104. PubMed ID: 3383123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bone metastasis by renal cell carcinoma. Importance of calcium and calcium-sensing receptor].
    Brenner W; Haber T; Junker K; Roos F; Thüroff JW
    Urologe A; 2015 Jun; 54(6):839-43. PubMed ID: 25503898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progression.
    Pan T; Liu F; Hao X; Wang S; Wasi M; Song JH; Lewis VO; Lin PP; Moon B; Bird JE; Panaretakis T; Lin SH; Wu D; Farach-Carson MC; Wang L; Zhang N; An Z; Zhang XH; Satcher RL
    Cancer Lett; 2024 Aug; 596():217009. PubMed ID: 38849015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition.
    Kausch I; Jiang H; Ewerdwalbesloh N; Doehn C; Krüger S; Sczakiel G; Jocham D
    BJU Int; 2005 Feb; 95(3):416-20. PubMed ID: 15679806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells.
    Loessner D; Stok KS; Lutolf MP; Hutmacher DW; Clements JA; Rizzi SC
    Biomaterials; 2010 Nov; 31(32):8494-506. PubMed ID: 20709389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression.
    Xiong F; Liu K; Zhang F; Sha K; Wang X; Guo X; Huang N
    Oncol Rep; 2016 May; 35(5):3000-8. PubMed ID: 26883716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
    Kominsky SL; Doucet M; Brady K; Weber KL
    J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of renal cancer stem cells from patient-derived xenografts.
    Hasmim M; Bruno S; Azzi S; Gallerne C; Michel JG; Chiabotto G; Lecoz V; Romei C; Spaggiari GM; Pezzolo A; Pistoia V; Angevin E; Gad S; Ferlicot S; Messai Y; Kieda C; Clay D; Sabatini F; Escudier B; Camussi G; Eid P; Azzarone B; Chouaib S
    Oncotarget; 2016 Mar; 7(13):15507-24. PubMed ID: 26551931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity.
    Lin YW; Lee LM; Lee WJ; Chu CY; Tan P; Yang YC; Chen WY; Yang SF; Hsiao M; Chien MH
    J Pineal Res; 2016 Apr; 60(3):277-90. PubMed ID: 26732239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-alpha inhibits in vitro osteoclast differentiation and renal cell carcinoma-induced angiogenesis.
    Avnet S; Cenni E; Perut F; Granchi D; Brandi ML; Giunti A; Baldini N
    Int J Oncol; 2007 Feb; 30(2):469-76. PubMed ID: 17203230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
    Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
    J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids.
    Iwai A; Fujii Y; Kawakami S; Takazawa R; Kageyama Y; Yoshida MA; Kihara K
    Mol Cell Endocrinol; 2004 Oct; 226(1-2):11-7. PubMed ID: 15489000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma.
    Paule B; Deslandes E; Le Mouel SP; Bastien L; Podgorniak MP; Allory Y; de la Taille A; Menashi S; Calvo F; Mourah S
    Int J Biol Markers; 2010; 25(2):112-5. PubMed ID: 20544684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
    Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
    Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
    Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
    Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
    Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY; Poellinger L; Walker CL
    Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.